Murata T, Yoshida M, Shiino S, Watase C, et al. Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer. Breast Cancer 2023 Aug 23. doi: 10.1007/s12282-023-01500.
PMID: 37612443